Monoclonal Antibody Sites Statewide Will Be Closed After FDA Removes Treatment Authorization
Full Story
Tallahassee, Fla. — This evening, without any advanced notice, the U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorizations (EUA) for bamlanivimab/etesevimab and REGEN-COV. The revised EUAs do not allow providers to administer these treatments within the United States.
Newsroom
Statewide Articles
- Florida Department of Health Welcomes New State Emergency Medical Services Medical Director
- Florida to Open Additional Monoclonal Antibody Therapy Treatment Sites
- Florida Department of Health Issues New COVID-19 Testing Guidance
- State Surgeon General Calls on Federal Government to Stop Actively Preventing Distribution of COVID-19 Therapeutics
Local Articles
- Clay County Annual Report 2019
- Coronavirus Updates (COVID-19)
- 2017 Annual Report Released
- FLORIDA HEALTH IN CLAY RECOGNIZES DIABETES AWARENESS MONTH
- Rabies Advisory
All Persons 5 Years of Age and Older Are Eligible to Receive the Vaccine In Florida
The Food & Drug Administration has approved the Pfizer COVID-19 vaccine for individuals 5 years of age or older. To obtain the vaccine in Florida, individuals 5-17 years of age must be accompanied by a guardian.
Full Story on FloridaHealth.gov
Featured Programs
Connect with DOH